Verastem Mesothelioma Clinical Trial Stopped Early For Futility
The Boston-based company Verastem has stopped its mesothelioma clinical trial early due to futile results in the Phase 2 study of VS-6063.
Category: alimta
Panel of Oncologists Say Obese People Less Likely to Survive Cancer
The findings have nothing to do with how they respond to treatment but, rather, how they are treated
Verastem Announces Start of Late-stage Trial for Meso Drug
The company’s president hopes they’ll be filing for FDA approval by the end of the trial.
Mesothelioma Cancer Drug Patent Threatened in Court By Generic Drug Makers
Eli Lilly and Co. Hoping That Adding Vitamin Supplements to Cancer Drug Treatment Will Save Patent
Potential Mesothelioma Drug Wins Orphan Status from the European Commission
Cambridge, Mass.-based Verastem hopes to bring to the table a new treatment option for patients with asbestos-caused cancer